Invention Grant
- Patent Title: PD-1/PD-L1 inhibitors
-
Application No.: US16660219Application Date: 2019-10-22
-
Publication No.: US11236085B2Publication Date: 2022-02-01
- Inventor: Zhimin Du , Michael Graupe , Paulo A. Machicao Tello , Jonathan William Medley , Samuel E. Metobo , Eric Q. Parkhill , Barton W. Phillips , Scott P. Simonovich , Peiyuan Wang , Jie Xu , Christopher A. Ziebenhaus
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D217/04 ; C07D401/12 ; C07D401/14 ; C07D413/10 ; C07D471/08 ; C07D487/04 ; C07D495/04 ; C07D513/04 ; C07K16/28 ; C07K16/40
Abstract:
Compounds and methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Public/Granted literature
- US20200157094A1 PD-1/PD-L1 INHIBITORS Public/Granted day:2020-05-21
Information query
